Showing 261 - 280 results of 439 for search '"Helicobacter pylori"', query time: 0.07s Refine Results
  1. 261
  2. 262
  3. 263

    Audit of Helicobacter pylori Testing in Microbiology Laboratories in England: To Inform Compliance with NICE Guidance and the Feasibility of Routine Antimicrobial Resistance Surveillance by Rosalie Allison, Donna M. Lecky, Megan Bull, Kim Turner, Gauri Godbole, Cliodna A. M. McNulty

    Published 2016-01-01
    “…The National Institute for Health and Clinical Excellence (NICE) guidance recommends that dyspeptic patients are tested for Helicobacter pylori using a urea breath test, stool antigen test, or serology. …”
    Get full text
    Article
  4. 264
  5. 265

    Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial by Atsushi Takagi, Hidetaka Yanagi, Hideki Ozawa, Naomi Uemura, Shigemi Nakajima, Kazuhiko Inoue, Takashi Kawai, Toshihiro Ohtsu, Yasuhiro Koga

    Published 2016-01-01
    “…Some Lactobacillus spp. suppress Helicobacter pylori in the stomach and have potential therapeutic applications for the treatment of gastrointestinal conditions. …”
    Get full text
    Article
  6. 266

    Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan by Wei-Chen Tai, Chien-Hua Chiu, Chih-Ming Liang, Kuo-Chin Chang, Chung-Mou Kuo, Yi-Chun Chiu, Keng-Liang Wu, Ming-Luen Hu, Yeh-Pin Chou, Shue-Shian Chiou, King-Wah Chiu, Chung-Huang Kuo, Tsung-Hui Hu, Ming-Tsung Lin, Seng-Kee Chuah

    Published 2013-01-01
    “…Second-line Helicobacter pylori (H. pylori) eradication with fluoroquinolone-containing triple therapy is one of the recommended treatment options, but neither 7-day nor 10-day regimens provide >90% success rates. …”
    Get full text
    Article
  7. 267

    Correlation between Quantitative 13C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort by Doron Boltin, Zohar Levi, Tsachi Tsadok Perets, Hemda Schmilovitz-Weiss, Rachel Gingold-Belfer, Ram Dickman, Iris Dotan

    Published 2018-01-01
    “…There are continual efforts to identify factors which influence the success of first-line therapy for Helicobacter pylori (H. pylori) infection. The 13C-urea breath test result (C13-UBT) utilizes H. pylori urease activity and is a highly accurate diagnostic assay. …”
    Get full text
    Article
  8. 268
  9. 269

    The association between helicobacter pylori infection and Triglyceride-Glucose (TyG) index in US adults: A retrospective cross-sectional study. by Wei Fu, Junlong Zhao, GuoBin Chen, Linya Lyu, Yao Ding, Liang-Bi Xu

    Published 2025-01-01
    “…<h4>Background</h4>The Triglyceride-glucose (TyG) index is a marker for insulin resistance and metabolic syndrome, while Helicobacter pylori is linked to gastrointestinal diseases and may affect metabolic risks. …”
    Get full text
    Article
  10. 270

    Active Peptic Ulcer Disease in Patients with Hepatitis C Virus-Related Cirrhosis: The Role of Helicobacter pylori Infection and Portal Hypertensive Gastropathy by Maria Dore, Daniela Mura, Stefania Deledda, Emmanouil Maragkoudakis, Antonella Pironti, Giuseppe Realdi

    Published 2004-01-01
    “…BACKGROUND & AIM: The relationship between Helicobacter pylori infection and peptic ulcer disease in cirrhosis remains controversial. …”
    Get full text
    Article
  11. 271

    α-Lipoic Acid Inhibits Helicobacter pylori-Induced Oncogene Expression and Hyperproliferation by Suppressing the Activation of NADPH Oxidase in Gastric Epithelial Cells by Eunyoung Byun, Joo Weon Lim, Jung Mogg Kim, Hyeyoung Kim

    Published 2014-01-01
    “…Hyperproliferation and oncogene expression are observed in the mucosa of Helicobacter pylori- (H. pylori-) infected patients with gastritis or adenocarcinoma. …”
    Get full text
    Article
  12. 272

    Helicobacter pylori infection and staple-line leak in patients with class III obesity undergoing laparoscopic sleeve gastrectomy: a retrospective study by Hani Tamim, Albaraa H Kazim, Fahad Y Bamehriz, Aldanah M Althwanay, Abdullah Aldohayan, Al-Bandari Zamil Abdullah, Bandar AlShehri, Rakan Masoud AlTuwayr, Habeeb I A Razack, Fahad Alsohaibani, Saleh A Alqahtani

    Published 2024-12-01
    “…Objective Globally, over 50% of the population is affected by Helicobacter pylori, yet research on its prevalence and impact in patients with obesity undergoing laparoscopic sleeve gastrectomy (LSG) is inconclusive. …”
    Get full text
    Article
  13. 273
  14. 274
  15. 275

    Rescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis by Xiaoqun Liu, Hui Wang, Zhifa Lv, Youhua Wang, Ben Wang, Yong Xie, Xiaojiang Zhou, Nonghua Lv

    Published 2015-01-01
    “…To conduct a systematic review and meta-analysis of clinical trials for eradication of Helicobacter pylori (H. pylori) that included a treatment arm with a proton pump inhibitor, rifabutin, and amoxicillin. …”
    Get full text
    Article
  16. 276

    Increased Cell Proliferation in Chronic Helicobacter pylori Positive Gastritis and Gastric Carcinoma – Correlation between Immuno-Histochemistry and Tv Image Cytometry by Erika Szaleczky, László Prónai, Béla Molnár, Lajos Berczi, János Fehér, Zsolt Tulassay

    Published 2000-01-01
    “…Backgound: Epithelial cell proliferation activity has been reported both to be unaltered and increased in Helicobacter pylori (H. pylori) associated chronic gastritis. …”
    Get full text
    Article
  17. 277
  18. 278
  19. 279
  20. 280